PTH and osteoporosis: Among current drug treatments for osteoporosis, a range of options such as bisphosphonates, SERMs, PTH and its analogs, RANKL inhibitors, and Sclerostin inhibitors have been confirmed to effectively increase bone density, decelerate bone loss, and lower fracture risks (41, 42).